{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:00:46Z","timestamp":1785261646712,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2668-6","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T14:25:35Z","timestamp":1527603935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-2063","authenticated-orcid":false,"given":"Matthew P.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lawandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Butler-Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katryn","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"issue":"12","key":"2668_CR1","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1086\/648442","volume":"49","author":"WI El Atrouni","year":"2009","unstructured":"El Atrouni WI, et al. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis. 2009;49(12):e130\u20138.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2668_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1017\/ice.2015.213","volume":"36","author":"Y Rhee","year":"2015","unstructured":"Rhee Y, et al. Evolving epidemiology of Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2015;36(12):1417\u201322.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2668_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1542-4758.2007.00156.x","volume":"11","author":"L Troidle","year":"2007","unstructured":"Troidle L, et al. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int. 2007;11(1):72\u20135.","journal-title":"Hemodial Int"},{"issue":"10","key":"2668_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/cid\/civ120","volume":"60","author":"AD Bai","year":"2015","unstructured":"Bai AD, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451\u201361.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2668_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/jamainternmed.2017.3958","volume":"177","author":"M Goto","year":"2017","unstructured":"Goto M, et al. Association of evidence-based care processes with mortality in staphylococcus aureus bacteremia at veterans health administration hospitals, 2003-2014. JAMA Intern Med. 2017;177(10):1489\u201397.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"2668_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.amjmed.2016.01.048","volume":"129","author":"MP Cheng","year":"2016","unstructured":"Cheng MP, Rene P, Cheng AP, Lee TC. Back to the Future: Penicillin-Susceptible Staphylococcus aureus. Am J Med. 2016;129(12):1331\u201333.","journal-title":"Am J Med"},{"issue":"5","key":"2668_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10096-016-2598-8","volume":"35","author":"D Yahav","year":"2016","unstructured":"Yahav D, et al. Risk factors for long-term mortality of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2016;35(5):785\u201390.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"2668_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","volume":"82","author":"FY Chang","year":"2003","unstructured":"Chang FY, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82(5):322\u201332.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"2668_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1086\/320001","volume":"32","author":"LA Mermel","year":"2001","unstructured":"Mermel LA, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32(9):1249\u201372.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2668_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1\u201345.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2668_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jac\/dku560","volume":"70","author":"AD Bai","year":"2015","unstructured":"Bai AD, et al. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother. 2015;70(5):1539\u201346.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2668_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/cid\/cix287","volume":"65","author":"JS McDanel","year":"2017","unstructured":"McDanel JS, et al. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis. 2017;65(1):100\u20136.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2668_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","volume":"97","author":"O Korzeniowski","year":"1982","unstructured":"Korzeniowski O, Sande MA. Combination antimicrobial therapy for staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97(4):496\u2013503.","journal-title":"Ann Intern Med"},{"key":"2668_CR14","doi-asserted-by":"crossref","unstructured":"Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86.","DOI":"10.1161\/CIR.0000000000000296"},{"issue":"2","key":"2668_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/cid\/civ808","volume":"62","author":"JS Davis","year":"2016","unstructured":"Davis JS, et al. Combination of vancomycin and \u03b2-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial. Clin Infect Dis. 2016;62(2):173\u201380.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2668_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13063-016-1295-3","volume":"17","author":"SYC Tong","year":"2016","unstructured":"Tong SYC, et al. CAMERA2 \u2013 combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials. 2016;17(1):170.","journal-title":"Trials"},{"issue":"1","key":"2668_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jac\/dkg288","volume":"52","author":"SS Richter","year":"2003","unstructured":"Richter SS, et al. The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother. 2003;52(1):123\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2668_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VGJ Fowler","year":"2006","unstructured":"Fowler VGJ, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7):653\u201365.","journal-title":"N Engl J Med"},{"issue":"9","key":"2668_CR19","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.bbamem.2006.02.009","volume":"1758","author":"SK Straus","year":"2006","unstructured":"Straus SK, Hancock REW. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta Biomembr. 2006;1758(9):1215\u201323.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"3","key":"2668_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jac\/dkh546","volume":"55","author":"JN Steenbergen","year":"2005","unstructured":"Steenbergen JN, et al. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother. 2005;55(3):283\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2668_CR21","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AAC.48.8.2871-2875.2004","volume":"48","author":"KH Rand","year":"2004","unstructured":"Rand KH, Houck HJ. Synergy of daptomycin with oxacillin and other \u03b2-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48(8):2871\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2668_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/cid\/cir340","volume":"53","author":"A Dhand","year":"2011","unstructured":"Dhand A, et al. Use of antistaphylococcal \u03b2-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011;53(2):158\u201363.","journal-title":"Clin Infect Dis"},{"key":"2668_CR23","doi-asserted-by":"crossref","unstructured":"Dhand A, Sakoulas G. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia. Clin Ther. 2014;36(10):1303\u201316.","DOI":"10.1016\/j.clinthera.2014.09.005"},{"issue":"2","key":"2668_CR24","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1128\/AAC.05551-11","volume":"56","author":"G Sakoulas","year":"2012","unstructured":"Sakoulas G, et al. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012;56(2):838\u201344.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2668_CR25","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1128\/AAC.02274-13","volume":"58","author":"G Sakoulas","year":"2014","unstructured":"Sakoulas G, et al. Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2014;58(3):1494\u2013500.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2668_CR26","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jac\/dkv007","volume":"70","author":"JR Smith","year":"2015","unstructured":"Smith JR, et al. \u03b2-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2015;70(6):1738\u201343.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2668_CR27","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1128\/AAC.01525-12","volume":"56","author":"S Mehta","year":"2012","unstructured":"Mehta S, et al. \u03b2-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives. Antimicrob Agents Chemother. 2012;56(12):6192\u2013200.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2668_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1179\/joc.2005.17.6.614","volume":"17","author":"DR Snydman","year":"2005","unstructured":"Snydman DR, McDermott LA, Jacobus NV. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves. J Chemother. 2005;17(6):614\u201321.","journal-title":"J Chemother"},{"issue":"1","key":"2668_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/AAC.01586-12","volume":"57","author":"BJ Werth","year":"2013","unstructured":"Werth BJ, et al. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model. Antimicrob Agents Chemother. 2013;57(1):66\u201373.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2668_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"3","key":"2668_CR31","first-page":"330","volume":"16","author":"MR Ardalan","year":"2005","unstructured":"Ardalan MR, et al. Aspergillosis after renal transplantation. Saudi J Kidney Dis Transpl. 2005;16(3):330\u20133.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"13\u201314","key":"2668_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/sim.4780131308","volume":"13","author":"DL DeMets","year":"1994","unstructured":"DeMets DL, Lan KK. Interim analysis: the alpha spending function approach. Stat Med. 1994;13(13\u201314):1341\u201352. discussion 1353-6","journal-title":"Stat Med"},{"issue":"12","key":"2668_CR33","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/AAC.01751-16","volume":"60","author":"G Butler-Laporte","year":"2016","unstructured":"Butler-Laporte G, et al. Using MRSA screening tests to predict methicillin resistance in Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2016;60(12):7444\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"2668_CR34","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","volume":"366","author":"DH Kang","year":"2012","unstructured":"Kang DH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466\u201373.","journal-title":"N Engl J Med"},{"key":"2668_CR35","doi-asserted-by":"crossref","unstructured":"Thwaites GE, Scarborough M, Szubert A, et al. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10121):668-78.","DOI":"10.1016\/S0140-6736(17)32456-X"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2668-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T15:03:38Z","timestamp":1661353418000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2668-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2668-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"25 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The DASH-RCT trial was reviewed and approved by the McGill University Health Center Research Ethics Board. Informed consent will be obtained from all patients recruited to the study prior to study participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"297"}}